News and Announcements
Leaf Resources (ASX: LER) Raises over $2m in Placements, Strengthens Board & Wins Awards
- Published July 17, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
In today’s society, consumers needs are shaping the demand for “greener and more natural products”, which can be seen throughout almost every industry. Leaf Resources, does exactly what society is demanding… focusing on the production of making sustainable products from plant biomass.
The commercialisation of Leaf’s GlycellTM process was significantly enhanced throughout 2017 with the following advancements: A first commercial scale facility in Malaysia has been identified, including a site in Johor offering potential engineering and construction advantages.
- Bio-based chemicals expert Bill Baum joined the Board as a Non-Executive Director.
- Doug Rathbone chemical engineer and former Nufarm Managing Director strengthens the Board .
- Ken Richards, voted the most innovative Bio-economy CEO.
- Raised over $2M in placements.
- Leaf Resources, was named #4 in “Hottest Emerging Company” in the Bio-economy in November, San Francisco.
- Presented at the 2017 Singapore Asia-Pacific Emerging Company Showcase.
Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
